Basal cell carcinoma of skin of scalp and neck
ICD-10 C44.41 is a billable code used to indicate a diagnosis of basal cell carcinoma of skin of scalp and neck.
Basal cell carcinoma (BCC) is the most common form of skin cancer, primarily arising from the basal cells in the epidermis. C44.41 specifically refers to BCC located on the scalp and neck, areas frequently exposed to ultraviolet (UV) radiation from the sun. This type of cancer is characterized by slow growth and a low likelihood of metastasis, but it can cause significant local tissue destruction if left untreated. Risk factors include prolonged sun exposure, fair skin, and a history of sunburns. Surgical excision is the primary treatment, with the goal of achieving clear surgical margins to minimize recurrence. Reconstruction may be necessary depending on the size and location of the excised lesion, particularly in cosmetically sensitive areas like the face and neck. Proper coding requires documentation of the tumor's size, location, and treatment plan, including any reconstructive procedures performed post-excision.
Detailed descriptions of the lesion, treatment plan, and follow-up care.
Diagnosis and treatment of BCC, Mohs micrographic surgery, and post-operative care.
Ensure clear documentation of margins and any reconstructive procedures performed.
Comprehensive treatment plans, including chemotherapy or radiation if applicable.
Management of advanced BCC cases and coordination of care with dermatology.
Document any systemic treatments and their indications.
Used when excising a BCC from the scalp or neck.
Document the size of the lesion and margins.
Dermatologists should ensure clear documentation of the excision and any reconstruction.
The primary treatment for basal cell carcinoma is surgical excision, often using Mohs micrographic surgery for high-risk areas to ensure clear margins.
